CARMAT: Funding, Investors & Team (Oct 2026)
CARMAT is a medical technology company that creates and produces bioprosthetic artificial hearts for the healthcare sector. The company specializes in developing total artificial hearts that closely resemble the structure of the human heart, including right and left ventricles. These artificial hearts are designed for patients with severe chronic or acute heart failure who are not eligible for a heart transplant and have tried all other treatment options. Founded in 2008, CARMAT aims to provide a reliable and innovative solution for patients suffering from heart failure. The company is located in Vélizy-Villacoublay.
CARMAT has raised $46.2M across 2 funding rounds on record, the most recent an undisclosed round of $2.4M announced in Jul 2024.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
CARMAT Company Profile and Key Stats
Latest funding round on record: Jul 2024.
CARMAT Funding Rounds
CARMAT raised $43.8M in a Post-IPO Equity announced in Apr 2022.
2.3 years later, an undisclosed round of $2.4M was announced in Jul 2024.
CARMAT Founders and Leadership Team
No contact details are on record for this team yet.
CARMAT Funding Compared to Other Health Care Startups
CARMAT's latest round of $2.4M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CARMAT in Health Care and Vélizy-villacoublay
Companies Similar to CARMAT
Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and…
Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of…
Beams is a producer of medical devices for cancerology based on the use of particles β.
Padoa is an occupational health software firm that develops a tool for monitoring the health of employees.…
CILcare specializes in providing drug solutions for hearing and ear disorders.
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials,…
noa is a digital fitness and wellness company that offers premium, structured training programs for strength,…
Semeia offers patient monitoring solution designed to support medical followup of patients, remotely and in…
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the…
Axomove is an e-wellbeing application that spends significant time in video actual activities.
Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate…
May Health has created a new solution for infertility caused by Polycystic Ovary Syndrome (PCOS) that is…
CARMAT Funding FAQs
What does CARMAT do?
CARMAT is a medical technology company that creates and produces bioprosthetic artificial hearts for the healthcare sector. The company specializes in developing total artificial hearts that closely resemble the structure of the human heart, including right and left ventricles. These artificial hearts are designed for patients with severe chronic or acute heart failure who are not eligible for a heart transplant and have tried all other treatment options. Founded in 2008, CARMAT aims to provide a reliable and innovative solution for patients suffering from heart failure. The company is located in Vélizy-Villacoublay.
How much funding has CARMAT raised?
CARMAT has raised $46.2M across 2 rounds on record. The most recent is an undisclosed round of $2.4M announced in Jul 2024.
When did CARMAT last raise funding?
CARMAT's most recent funding round on record is an undisclosed round of $2.4M, announced in Jul 2024.
Who founded CARMAT?
FundedIQ lists Gafa Ruti (Founder) at CARMAT.
Who is the CEO of CARMAT?
Marcello Conviti is listed as CEO at CARMAT.
Where is CARMAT headquartered?
CARMAT is based in Vélizy-villacoublay, Ile-De-France, France.
How many employees does CARMAT have?
CARMAT is in the 101-250 employee band.
How does CARMAT's funding compare to other Health Care startups?
CARMAT's latest round of $2.4M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's CARMAT Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CARMAT is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.